Remove 2025 Remove Bioinformatics Remove Pharmacy
article thumbnail

From siloed data to breakthroughs: multimodal AI in drug discovery

Drug Target Review

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. The Rise of Multimodal Language Models in Drug Development (2025).

Drugs 64
article thumbnail

Early evidence and emerging trends: How AI is shaping drug discovery and clinical development

Drug Target Review

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. 2024 [cited 2025 Feb 7]. Velez (2025). Using clinical genomics and AI in drug development to elevate success.

article thumbnail

Navigating the AI revolution: a roadmap for pharma’s future

Drug Target Review

Surveys (eg, 2024 State of Tech in Biopharma Report ) predict a doubling of R&D data year-over-year in 2025, highlighting the continued growth of available data. This article, along with other insightful analyses, will be featured in our upcoming report, Beyond the Lab – Artificial Intelligence, launching on 21st March 2025.